Examining the clinical profile of nelotanserin, a novel agent in development for Lewy body dementia
Objective: To examine the clinical profile of nelotanserin, a novel agent in development for the treatment of Lewy body dementia. Background: Although not FDA-approved for…Disrupted motor memory in Parkinson’s disease
Objective: We sought to investigate the differences in motor adaptation and motor memory between people with Parkinson's disease (PD) and healthy age-matched controls by using…Curcumin supplementation improves motor dysfunction in lipopolysaccharide induced Parkinon’s disease model: Possible biochemical, neurochemical and immunohistochemical alterations in rats
Objective: In the present study potential neuroprotective effects of curcumin were tested to determine if they could help to minimize microglia–mediated damage in single intranigral…Cognitive and behavioral problems in children and adolescents with myoclonus dystonia
Objective: To compare the neuropsychological and behavioral profile of A) children and adolescents with myoclonus dystonia (MD) to a healthy control group and B) MD…Effectivity and safety of rotigotine transdermal patch on motor and cognitive dysfunctions in Parkinson’s disease with dementia and dementia with Lewy bodies
Objective: This study aimed to demonstrate effectivity and safety of rotigotine transdermal patch (RTP) on motor and cognitive dysfunctions in patients with Parkinson's disease with…The effect of dopamine on global versus specific inhibitory control in Parkinson’s disease
Objective: To evaluate the effect of dopaminergic medication on inhibitory control using a novel go/no-go task in Parkinson's disease (PD). Global cognition and motor examination…Exploring therapeutic viability of a non-dopaminergic target for Parkinson’s disease
Objective: Non-dopaminergic protein drug targets are of high interest to develop adjuvant treatments for currently insufficiently addressed symptoms of PD. RGS4, a regulator of G-protein…Cognitive and behavioral side effects in patients treated with droxidopa for neurogenic orthostatic hypotension
Objective: To describe adverse behavioral symptoms attributed to droxidopa therapy for neurogenic orthostatic hypotension (nOH). Background: Droxidopa, a norepinephrine (NE) precursor, improves symptoms of neurogenic…Smell perception and judgement in PD patients: Results of a study designed, conducted, analysed and reported by PD patients
Objective: The objective of this study was to investigate smell impairment in PD and the role of judgement in sensory accuracy. Background: The sense of…Neuropsychological correlates of impulse control disorders and punding in Parkinson´ s disease
Objective: To investigate the relationship between cognitive deficits, Impulse Control Disorders (ICDs) and Punding in Parkinson's disease (PD). Background: The neuropsychological correlates of ICDs and…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.